USPlabs Jack3d™ University Studies Completed

USPlabs, LLC, manufacturer of ultra-premium dietary supplements, announced two separate university studies have been completed on USPlabs Jack3d™.

Dallas, TX (PRWEB) August 8, 2010

USPlabs, LLC, manufacturer of ultra-premium dietary supplements, announced two separate university studies have been completed on USPlabs Jack3d™.

Study #1

The dietary supplement Jack3d ™ was recently investigated using a placebo controlled, double-blind, cross-over design for safety and efficacy at a Tier-1 Research University within the United States.

In this study, 11 resistance-trained men reported to the laboratory and ingested either Jack3d ™ or a placebo.

After the condition was consumed, subjects were evaluated to determine muscular power, strength and endurance.

Preliminary results indicated that Jack3d ™ may be a useful aid for trained athletes which desire an improvement in some of these measured parameters.

Detailed results from this work should be available in a peer reviewed manuscript format within the next several months.

Study #2

In addition, a more long-term intervention assessing safety has also been completed which found no serious adverse events in normal healthy humans.

Detailed results from this work should also be available in a peer reviewed manuscript format within the next several months.

About USPlabs

USPlabs, LLC is a dietary supplement company specializing in ultra-premium sports supplements. Its products are currently available at fine retail locations both nationwide and internationally. For more information, visit http://www.USPlabsdirect.com

Contact

Casey Bard

Casey(dot)Bard(at)usplabsdirect(dot)com

###


Contact Information
Casey Bard
USPlabs
http://www.USPlabsDirect.com
469-737-9074

Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2012, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy